FindTrial
Sign In

Risk factors and long-term survival of symptomatic anastomotic leakage after laparoscopic low anterior resection for rectal cancer: a retrospective study of 298 consecutive patients from China

Risk factors and long-term survival of symptomatic anastomotic leakage after laparoscopic low anterior resection for rectal cancer: a retrospective study of 298 consecutive patients from China

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033413
Enrollment
Unknown
Registered
2020-05-31
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer

Interventions

Anastomotic leakage (-):Laparoscopic low anterior resection for rectal cancer
Anastomotic leakage (+):Laparoscopic low anterior resection for rectal cancer

Sponsors

Peking University Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Preoperative pathology confirmed as primary rectal cancer. 2. Inclusion time: May 2009-May 2015. 3. Surgery: Laparoscopic anterior resection

Exclusion criteria

Exclusion criteria: 1. Surgery: laparotomy or transfer to laparotomy in surgery; 2. Emergency surgery; 3. Patients with incomplete baseline data; 4. Pregnant and lactating patients; 5. Contraindications for surgery.

Design outcomes

Primary

MeasureTime frame
Gender;Age;ASA category;Smoking;Alcohol consumption;Previous history of abdominal surger;Preoperative intestinal obstruction;Hypertension;Diabetes;BMI;Neoadjuvant therapy;Pulmonary insufficiency;Preoperative hemoglobin;Preoperative white blood cell;Preoperative serum albumin;Preoperative CEA;Distance from the anal verge;Duration of operation;Intraoperative blood loss;Combined organ resection;Intraoperative blood transfusion;Defunctioning stoma;Transanal tube drainage;Pathology type of tumor;Size of tumor;Tumor differentiation;Tumor type;Tumor infiltrating;Vascular invasion;Nerve invasion;Pathological tumor(T)category;Pathological node(N)category;Metastasis;Cancerous node;Three-year overall survival;Five-year overall survival;—

Countries

Chian

Contacts

Public ContactMing Cui

Peking University Cancer Hospital

cuiming@bjmu.edu.cn+86 13366527310

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026